Estrogen signaling plays a critical role in the pathogenesis of breast cancer.Because the majority of breast carcinomas express the estrogen receptor ERα,endocrine therapy that impedes estrogen-ER signaling reduces breast cancermortality and has become a mainstay of breast cancer treatment. This evidence concerns the gene ESR1 and breast cancer.